Video Experimental Relacionado
Updated: Sep 9, 2025
07:38
A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice
Published on: April 13, 2018
11.6K
Terapias emergentes en la EPOC: mapeo de la innovación a rasgos tratables
Mario Cazzola1, Vanessa M McDonald2,3, Daiana Stolz4
1Unit of Respiratory Medicine, Department of Experimental Medicine, University of Rome 'Tor Vergata', Rome, Italy. mario.cazzola@uniroma2.it.
Lung
|September 3, 2025
Resumen
El enfoque de los rasgos tratables (TTs) personaliza el manejo de la enfermedad pulmonar obstructiva crónica (EPOC) dirigiéndose a rasgos específicos del paciente con nuevas terapias. Esta estrategia de medicina de precisión tiene como objetivo mejorar los resultados para los pacientes con EPOC al ir más allá de los tratamientos de talla única.
Área de la Ciencia:
- Medicina de los pulmones
- Farmacología
- Medicina de precisión
Sus antecedentes:
- La enfermedad pulmonar obstructiva crónica (EPOC) es una condición heterogénea con diversos fenotipos y patobiología.
- Las estrategias de manejo actuales a menudo fallan debido a su naturaleza de "talla única para todos", lo que limita la efectividad en el tratamiento de la heterogeneidad de los pacientes.
Objetivo del estudio:
- Explorar la sinergia entre el marco de las características tratables y las terapias farmacológicas emergentes para la EPOC.
- Trazar un mapa de los nuevos agentes antiinflamatorios y broncodilatadores para las TT específicas y modificables en pacientes con EPOC.
Principales métodos:
- Revisión y análisis de las terapias farmacológicas emergentes en relación con el marco TT.
- La asignación de las categorías de fármacos (por ejemplo, antiinflamatorios, broncodilatadores) a las TT pertinentes (por ejemplo, inflamación eosinofílica, bronquitis crónica, exacerbaciones).
- Enfoque en el fenotipo basado en biomarcadores y datos del mundo real para el diseño de ensayos clínicos basados en TT.
Principales resultados:
- Las terapias emergentes, en particular los agentes antiinflamatorios y los broncodilatadores, se pueden alinear con TTs específicos.
- El fenotipo basado en biomarcadores es crucial para el diseño eficaz de ensayos basados en TT.
- Los desafíos incluyen inestabilidad de rasgos, agrupación de comorbilidad y heterogeneidad del diseño del ensayo.
Conclusiones:
- La integración de terapias emergentes con el enfoque TTs ofrece un camino prometedor para el manejo personalizado de la EPOC.
- Este paradigma de medicina de precisión puede mejorar los resultados de los pacientes y guiar el desarrollo de fármacos específicos.
- La incorporación de la salud digital, el seguimiento a largo plazo y la rentabilidad es vital para la relevancia de la traducción.
Videos de Conceptos Relacionados
01:20COPD: Pathogenesis and Clinical Features
516
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
516
01:26COPD: Management Using Bronchodilators and Corticosteroids
305
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
305
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.7K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.9K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.1K
01:22Chronic Obstructive Pulmonary Disease
1.4K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.4K